annual SGA:
$68.90M+$22.36M(+48.05%)Summary
- As of today (September 10, 2025), XENE annual SGA is $68.90 million, with the most recent change of +$22.36 million (+48.05%) on December 31, 2024.
- During the last 3 years, XENE annual SGA has risen by +$46.94 million (+213.67%).
- XENE annual SGA is now at all-time high.
Performance
XENE SGA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly SGA:
$0.00-$19.04M(-100.00%)Summary
- As of today (September 10, 2025), XENE quarterly SGA is $0.00, with the most recent change of -$19.04 million (-100.00%) on June 1, 2025.
- Over the past year, XENE quarterly SGA has dropped by -$19.40 million (-100.00%).
- XENE quarterly SGA is now -100.00% below its all-time high of $19.40 million, reached on June 30, 2024.
Performance
XENE quarterly SGA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM SGA:
-$3.75B-$278.23M(-8.02%)Summary
- As of today (September 10, 2025), XENE TTM SGA is -$3.75 billion, with the most recent change of -$278.23 million (-8.02%) on June 1, 2025.
- Over the past year, XENE TTM SGA has dropped by -$3.81 billion (-6385.22%).
- XENE TTM SGA is now -3109.36% below its all-time high of -$116.75 million.
Performance
XENE TTM SGA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Selling, general & administrative expenses Formula
SGA = Total Operating Expenses - Cost of Goods Sold - Research & Development
XENE Selling, general & administrative expenses Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +48.0% | -100.0% | -6385.2% |
| 3 y3 years | +213.7% | -100.0% | -10000.0% |
| 5 y5 years | +537.8% | -100.0% | -10000.0% |
XENE Selling, general & administrative expenses Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +213.7% | -100.0% | at low | -154.1% | at low |
| 5 y | 5-year | at high | +537.8% | -100.0% | at low | -273.8% | at low |
| alltime | all time | at high | +1190.1% | -100.0% | at low | -3109.4% | at low |
XENE Selling, general & administrative expenses History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2025 | - | $0.00(-100.0%) | $35.74M(-35.2%) |
| Mar 2025 | - | $19.04M(>+9900.0%) | $55.15M(+8.3%) |
| Dec 2024 | $68.90M(+48.0%) | $0.00(-100.0%) | $50.90M(-19.9%) |
| Sep 2024 | - | $16.71M(-13.9%) | $63.52M(+6.5%) |
| Jun 2024 | - | $19.40M(+31.2%) | $59.62M(+15.1%) |
| Mar 2024 | - | $14.79M(+17.2%) | $51.80M(+11.3%) |
| Dec 2023 | $46.54M(+41.9%) | $12.62M(-1.4%) | $46.54M(+9.7%) |
| Sep 2023 | - | $12.80M(+10.5%) | $42.42M(+10.3%) |
| Jun 2023 | - | $11.58M(+21.5%) | $38.45M(+8.1%) |
| Mar 2023 | - | $9.54M(+12.2%) | $35.57M(+8.4%) |
| Dec 2022 | $32.81M(+49.4%) | $8.50M(-3.7%) | $32.81M(+5.8%) |
| Sep 2022 | - | $8.83M(+1.4%) | $31.00M(+14.8%) |
| Jun 2022 | - | $8.71M(+28.5%) | $27.00M(+9.6%) |
| Mar 2022 | - | $6.78M(+1.3%) | $24.63M(+12.1%) |
| Dec 2021 | $21.97M(+69.7%) | $6.69M(+38.4%) | $21.97M(+19.5%) |
| Sep 2021 | - | $4.83M(-23.8%) | $18.39M(+9.7%) |
| Jun 2021 | - | $6.34M(+54.3%) | $16.76M(+22.1%) |
| Mar 2021 | - | $4.11M(+32.3%) | $13.73M(+6.1%) |
| Dec 2020 | $12.94M(+19.8%) | $3.11M(-3.2%) | $12.94M(-0.5%) |
| Sep 2020 | - | $3.21M(-3.1%) | $13.01M(+4.1%) |
| Jun 2020 | - | $3.31M(-0.3%) | $12.51M(+8.7%) |
| Mar 2020 | - | $3.32M(+4.6%) | $11.50M(+6.5%) |
| Dec 2019 | $10.80M(+28.5%) | $3.17M(+17.6%) | $10.80M(+11.9%) |
| Sep 2019 | - | $2.70M(+17.0%) | $9.66M(+8.6%) |
| Jun 2019 | - | $2.31M(-12.0%) | $8.89M(+1.5%) |
| Mar 2019 | - | $2.62M(+29.2%) | $8.77M(+4.6%) |
| Dec 2018 | $8.41M(+14.9%) | $2.03M(+4.6%) | $8.38M(+4.5%) |
| Sep 2018 | - | $1.94M(-11.0%) | $8.02M(+2.5%) |
| Jun 2018 | - | $2.18M(-2.7%) | $7.83M(+5.1%) |
| Mar 2018 | - | $2.24M(+34.0%) | $7.45M(+1.9%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2017 | $7.31M(+7.7%) | $1.67M(-4.2%) | $7.31M(+3.2%) |
| Sep 2017 | - | $1.74M(-3.1%) | $7.08M(-0.5%) |
| Jun 2017 | - | $1.80M(-14.3%) | $7.12M(+1.8%) |
| Mar 2017 | - | $2.10M(+45.6%) | $7.00M(+3.0%) |
| Dec 2016 | $6.79M(-30.6%) | $1.44M(-18.9%) | $6.79M(-1.8%) |
| Sep 2016 | - | $1.78M(+6.1%) | $6.92M(+7.1%) |
| Jun 2016 | - | $1.68M(-11.6%) | $6.46M(+30.2%) |
| Mar 2016 | - | $1.90M(+20.9%) | $4.96M(+2.2%) |
| Dec 2015 | $9.79M(+78.1%) | $1.57M(+18.6%) | $4.86M(+3.8%) |
| Sep 2015 | - | $1.32M(+642.1%) | $4.68M(+0.1%) |
| Jun 2015 | - | $178.00K(-90.1%) | $4.67M(+4.0%) |
| Mar 2015 | - | $1.79M(+28.7%) | $4.50M(+66.1%) |
| Dec 2014 | $5.50M(+2.9%) | $1.39M(+5.6%) | $2.71M(+105.6%) |
| Sep 2014 | - | $1.32M(>+9900.0%) | $1.32M(>+9900.0%) |
| Jun 2014 | - | $0.00(0.0%) | $0.00(0.0%) |
| Mar 2014 | - | $0.00(0.0%) | $0.00(0.0%) |
| Dec 2013 | $5.34M(-23.8%) | $0.00(0.0%) | $0.00(0.0%) |
| Sep 2013 | - | $0.00(0.0%) | $0.00(0.0%) |
| Jun 2013 | - | $0.00(0.0%) | $0.00(0.0%) |
| Mar 2013 | - | $0.00(0.0%) | $0.00(0.0%) |
| Dec 2012 | $7.01M(+4.1%) | - | - |
| Dec 2012 | - | $0.00(0.0%) | $0.00(0.0%) |
| Sep 2012 | - | $0.00(0.0%) | $0.00(0.0%) |
| Jun 2012 | - | $0.00(0.0%) | $0.00(0.0%) |
| Mar 2012 | - | $0.00(0.0%) | $0.00(0.0%) |
| Dec 2011 | $6.73M | - | - |
| Dec 2011 | - | $0.00(0.0%) | $0.00(0.0%) |
| Sep 2011 | - | $0.00(0.0%) | $0.00(0.0%) |
| Jun 2011 | - | $0.00(0.0%) | $0.00(0.0%) |
| Mar 2011 | - | $0.00 | $0.00 |
FAQ
- What is Xenon Pharmaceuticals Inc. annual SGA?
- What is the all time high annual SGA for Xenon Pharmaceuticals Inc.?
- What is Xenon Pharmaceuticals Inc. annual SGA year-on-year change?
- What is Xenon Pharmaceuticals Inc. quarterly SGA?
- What is the all time high quarterly SGA for Xenon Pharmaceuticals Inc.?
- What is Xenon Pharmaceuticals Inc. quarterly SGA year-on-year change?
- What is Xenon Pharmaceuticals Inc. TTM SGA?
- What is the all time high TTM SGA for Xenon Pharmaceuticals Inc.?
- What is Xenon Pharmaceuticals Inc. TTM SGA year-on-year change?
What is Xenon Pharmaceuticals Inc. annual SGA?
The current annual SGA of XENE is $68.90M
What is the all time high annual SGA for Xenon Pharmaceuticals Inc.?
Xenon Pharmaceuticals Inc. all-time high annual SGA is $68.90M
What is Xenon Pharmaceuticals Inc. annual SGA year-on-year change?
Over the past year, XENE annual SGA has changed by +$22.36M (+48.05%)
What is Xenon Pharmaceuticals Inc. quarterly SGA?
The current quarterly SGA of XENE is $0.00
What is the all time high quarterly SGA for Xenon Pharmaceuticals Inc.?
Xenon Pharmaceuticals Inc. all-time high quarterly SGA is $19.40M
What is Xenon Pharmaceuticals Inc. quarterly SGA year-on-year change?
Over the past year, XENE quarterly SGA has changed by -$19.40M (-100.00%)
What is Xenon Pharmaceuticals Inc. TTM SGA?
The current TTM SGA of XENE is -$3.75B
What is the all time high TTM SGA for Xenon Pharmaceuticals Inc.?
Xenon Pharmaceuticals Inc. all-time high TTM SGA is -$116.75M
What is Xenon Pharmaceuticals Inc. TTM SGA year-on-year change?
Over the past year, XENE TTM SGA has changed by -$3.81B (-6385.22%)